Table 1.
Correlation Between APOC1 Expression and Clinicopathological Characteristics of Cervical Cancer Patients
| Characteristics | Total | Expression of APOC1 | P value | |
|---|---|---|---|---|
| High | Low | |||
| (n=24) | (n=12) | |||
| Tumor size (cm) | ||||
| <3cm | 17 | 12(70.6%) | 5(29.4%) | 0.732 |
| ≥3cm | 19 | 12(63.2%) | 7(36.8%) | |
| Age | ||||
| <50 | 13 | 7(53.8%) | 6(46.2%) | 0.281 |
| ≥50 | 23 | 17(73.9%) | 6(26.1%) | |
| Serum SCCA | ||||
| ≤ 5 | 22 | 20(90.9%) | 2(9.1%) | 0.000** |
| >5 | 14 | 4(28.6%) | 10(71.4%) | |
| Tumor differentiation | ||||
| Medium-low | 11 | 3(27.3%) | 8(72.7%) | 0.002** |
| High | 25 | 21(84.0%) | 4(16.0%) | |
| FIGO staging | ||||
| I-II | 27 | 15(55.6%) | 12(44.4%) | 0.016* |
| III-IV | 9 | 9(100.0%) | 0(0.00%) | |
| Lymph node metastasis (N) | ||||
| N0 | 34 | 22(64.7%) | 12(35.3%) | 0.543 |
| N1 or above | 2 | 2(100%) | 0(0.00%) | |
Notes: *P < 0.05,**P < 0.01
Abbreviations: SCCA, squamous cell carcinoma antigen; FIGO staging, the Cervical Cancer Staging System of International Federation of Gynecology and Obstetrics in 2014.